Harold Bernstein, President, R&D & CMO: Maze Therapeutics MAZE Planned sale · Filed 25/12/29

Trade details

Type: Planned sale notice
Stock: Maze Therapeutics MAZE
Person: Harold BernsteinPresident, R&D & CMO
Planned sale date: 25/12/29
Filed: 25/12/29

0.2% of shares outstanding to be sold

Maze Therapeutics trades, last 26 weeks

What else happened in Maze Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/29~01/28

Harold Bernstein's recent trades

Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$438.7K
16,141 sh
$438.7K
Filed 10/01
Traded 10/01
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$251.1K
9,705 sh
$251.1K
Filed 09/04
Traded 09/04
Harold BernsteinPresident, R&D & CMO
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$283.5K
10,685 sh
$283.5K
Filed 09/02
Traded 09/02
Harold BernsteinPresident, R&D & CMO
Planned sale10b5-1 planMaze Therapeutics
Planned sale10b5-1 plan
Maze Therapeutics
MAZE
$1.4M
46,892 sh
$1.4M
Filed 07/01
Traded 07/01
Harold BernsteinPresident, R&D & CMO
Sell10b5-1 planMaze Therapeutics
Sell10b5-1 plan
Maze Therapeutics
MAZE
$338.9K
13,253 sh
$338.9K
Filed 06/03
Traded 06/01

Harold Bernstein, CMO — plans to sell 105,000 sh of Maze Therapeutics MAZE · $4.4M · around 12/29 · 10b5-1 plan | Whalegun